0.000USD0.000åå ŽååŒÂ 07/24, 09:30 (ET)
6.14BæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
46.820å§å€
49.500é«å€
2.99Måºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
æå€±é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
2.34%売買å転ç
47.050忥çµå€
46.820å®å€
115.00M売買代é
æå€±é¡æ ªäŸ¡åçç
7.71PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-2.36%ç·è³ç£å©çç
28.17052é±é«å€
1.00åºæ¥é«æ¯ç%
-182.63MçŽå©ç
127.69Mæ ªåŒæ°
-0.17381æ ªåœããå©çïŒEPSïŒ
2.11ããŒã¿å€
-2.98%èªå·±è³æ¬å©çç
8.81052é±å®å€
5.70%æ¯ãå¹
70.39%ç²å©çç
6.14BæäŸ¡ç·é¡
8.89ãªã¹ã¯ãªã¿ãŒã³
4.05%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-23 äž»èŠã€ã³ãµã€ã
10X Genomics Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»çæ©åš & å忥çã§ã®é äœã¯200äž25äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯38.46ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã«ãããæ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯è¯å¥œã§ããã¡ã³ãã¡ã³ã¿ã«ãºãåªããŠããŸãããããã¯ãã«ã«ã¯çŸåšã®ãã¬ã³ããè£ä»ãããã®ã§ã¯ãããŸãããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
10X Genomics Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
10X Genomics Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
10X Genomics Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Zimmer Biomet Holdings Inc
ZBH
31
ææšî
ææš
売ã(1)
äžç«(0)
è²·ã(3)
ç§»åå¹³å
売ã(0)
äžç«(0)
è²·ã(6)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
10X Genomics Incã®äŒæ¥æ
å ±î
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
äŒæ¥ã³ãŒãTXG
äŒæ¥å10X Genomics Inc
æé«çµå¶è²¬ä»»è
ãCEOãSaxonov (Serge Wilson)
ãŠã§ããµã€ãhttps://www.10xgenomics.com/
æ ªäž»çµ±èšî
ãããã質å
10X Genomics IncïŒTXGïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
î10X Genomics IncïŒTXGïŒã®çŸåšã®æ ªäŸ¡ã¯48.10ã§ãã
10X Genomics Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
î10X Genomics Incã®ãã£ãã«ãŒã·ã³ãã«ã¯TXGã§ãã
10X Genomics Incã®52é±é«å€ã¯ãããã§ããïŒ
î10X Genomics Incã®52é±é«å€ã¯28.17ã§ãã
10X Genomics Incã®52é±å®å€ã¯ãããã§ããïŒ
î10X Genomics Incã®52é±å®å€ã¯8.81ã§ãã
10X Genomics Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
î10X Genomics Incã®æäŸ¡ç·é¡ã¯6.14Bã§ãã
10X Genomics Inc (TXG) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšã10X Genomics IncïŒTXGïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯38.46ã§ãã
10X Genomics Inc (TXG) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
î10X Genomics IncïŒTXGïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.35ã§ãã